VitaDAO

Founded 2021

51–200 people

Stage: No stage info

Get updates & announcements

About

VitaDAO is a community for people who are proactively working towards a better quality of life as they age. We support the researchers who are working to develop therapies to solve age-related diseases in a way that may change the outcomes of aging for everyone in our lifetime.

Contact Details

https://discord.com/invite/3S3ftnmZYD

https://www.vitadao.com

https://www.vitadao.com/blog

Community Affiliations

Members (2)

Laurence Ion

Founding Steward

Victoria Forest

Awarness Group

Focus Areas

Projects (1)

Aubrai

The world’s first decentralized longevity agent

VitaDAO News (3)

Michael Torres, PhD joins VitaDAO as Core Advisor

Torres (CrossBridge Bio founder, sold to Eli Lilly for up to $300M) will steer VitaRNA science, help build the crypto×biotech playbook, and advise on pipeline and partnerships.

Fundingvitadao.substack.com4 months ago

13 Views

VitaDAO-backed ARTAN Bio closes $1M seed round to advance tRNA longevity platform

Led by co-founder Michael Torres (ex-CrossBridge Bio, acquired by Eli Lilly), the raise funds IND-enabling studies; governance rights are tokenized via the $VITARNA IP-NFT on Molecule.

Fundingprnewswire.com4 months ago

13 Views

ARTAN Bio announced a $200,000 seed raise to advance its longevity biotechnology platform (mutation-specific codon suppression for aging-related diseases), crediting earlier seed…

Jun 4, 2026 — ARTAN Bio announced a $200,000 seed raise to advance its longevity biotechnology platform (mutation-specific codon suppression for aging-related diseases), crediting earlier seed validation funding from VitaDAO. The company's CEO presented the VitaDAO partnership and DeSci model at the NFC Summit in Lisbon on June 4, 2026.

Fundingprnewswire.com5 months ago

13 Views

All network updates